Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Xtant Medical Holdings (XTNT) EBT Margin (2016 - 2025)

Xtant Medical Holdings (XTNT) has disclosed EBT Margin for 16 consecutive years, with 4.71% as the latest value for Q3 2025.

  • On a quarterly basis, EBT Margin rose 2247.0% to 4.71% in Q3 2025 year-over-year; TTM through Sep 2025 was 1.7%, a 1649.0% increase, with the full-year FY2024 number at 13.87%, down 1273.0% from a year prior.
  • EBT Margin was 4.71% for Q3 2025 at Xtant Medical Holdings, down from 10.75% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 27.7% in Q3 2023 to a low of 17.76% in Q3 2024.
  • A 5-year average of 7.45% and a median of 11.51% in 2023 define the central range for EBT Margin.
  • Peak YoY movement for EBT Margin: soared 4388bps in 2023, then tumbled -4546bps in 2024.
  • Xtant Medical Holdings' EBT Margin stood at 17.08% in 2021, then grew by 16bps to 14.34% in 2022, then rose by 8bps to 13.26% in 2023, then rose by 25bps to 9.98% in 2024, then soared by 147bps to 4.71% in 2025.
  • Per Business Quant, the three most recent readings for XTNT's EBT Margin are 4.71% (Q3 2025), 10.75% (Q2 2025), and 0.1% (Q1 2025).